Parplus Partners’s Merck MRK Stock Holding History

Parplus Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-9,330	Closed	-$810K	–	91
2019 Q4	$810K	Buy	+9,330	New	+$766K	0.16%	17

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parplus Partners's MRK Position: Q1 2020 in Review

Parplus Partners sold out of Merck (MRK) in Q1 2020, closing a stake of 9,330 shares — an estimated $810K sold.

Parplus Partners first reported a position in MRK in Q4 2019 and held it in 1 quarter. The position peaked at $810K in Q4 2019. 2,477 funds tracked by Wall St. Rank hold MRK as of Q1 2020.

Parplus Partners reported no remaining Merck position as of Q1 2020 after selling out during the quarter.
Parplus Partners sold 9,330 Merck shares in Q1 2020, an estimated $810K.
Parplus Partners first reported a position in Merck in Q4 2019 and held it in 1 quarter.
Parplus Partners's Merck position peaked at $810K in Q4 2019.
2,477 funds tracked by Wall St. Rank held Merck as of Q1 2020.

Based on Parplus Partners's 13F filing for Q1 2020, filed 14 May 2020.